SOURCES SOUGHT
J -- Preventive Maintenance/Service Agreement for Cytometer System
- Notice Date
- 11/21/2013
- Notice Type
- Sources Sought
- NAICS
- 811219
— Other Electronic and Precision Equipment Repair and Maintenance
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA_1127464
- Archive Date
- 12/18/2013
- Point of Contact
- Sondea R Blair, Phone: 8705437469
- E-Mail Address
-
sondea.blair@fda.hhs.gov
(sondea.blair@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION The U.S. Food and Drug Administration (FDA), is conducting market research to support the National Center for Toxicological Research's service requirement for Preventive Maintenance/Service Agreement for a Cytometer System. This sources sought notice is being issued to determine the existence of US small businesses capable of satisfying our requirement. The associated North American Industry Classification System (NAICS) Code is 811219 - Other Electronic and Precision Equipment Repair and Maintenance ; Small Business Size Standard is $19 million in assets. Background: The FDA's, Center for Biologics Evaluation and Research (CBER) requires a Preventive Maintenance/Service Agreement for a Cytometer System, specifically a Guava 8HT Model 0500-4008B, Serial Number 6735128112, manufactured by EMD Millipore Corporation. The service plan is necessary to ensure the Cytomeyter system is maintained in optimal working condition for various experiments and assays as the system is critical for cell analysis used in cell substrates experiment and must be finely calibrated in order to sustain the integrity of ongoing and future experiments. Minimum Requirements: •Shall include one (1) planned preventative maintenance visit per contract year. •Shall include unlimited corrective/remedial maintenance visits within 3 business days of call for service •Shall include unlimited technical support, Mondays - Fridays (excluding Federal Holidays) between the hours of 7:00 AM - 5:00 PM Eastern Time, within 8 business hours of contact for assistance (e.g., telephone-based, email-based, website-based, etc.) •Shall include unlimited software and firmware updates. •All maintenance and repair activities shall be performed by formally trained and certified technicians/engineers, following Original Equipment Manufacturer (OEM) specifications, manuals, and service bulletins, using OEM replacement parts, components, subassemblies, etc. •All maintenance pricing shall be inclusive of labor, travel, replacement parts, components, subassemblies, etc. Base Contract Period of Performance: 1/14/2014 to 1/13/2015 Price ________________ Option Year One Period of Performance: 1/14/2015 to 1/13/2016 Price ________________ Option Year Two Period of Performance: 1/14/2016 to 1/13/2017 Price ________________ Option Year Three Period of Performance: 1/14/2017 to 1/13/2018 Price ________________ Option Year Four Period of Performance: 1/14/2018 to 1/13/2019 Price ________________ Total Contract Price______________________ Place of Performance Work shall be performed on-site at the contractor location with deliverables sent to the following Government location: US Food and Drug Administration Center for Biologics Evaluation and Research NIH Campus, Bldg 29B, Room 3G11 8800 Rockville Pike Bethesda, MD 20892 Responses to this sources sought shall unequivocally demonstrate that the respondent is regularly engaged in providing the required services. Though the target audience is small businesses, all interested parties may respond. At a minimum, responses shall include the following: •Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address. •Past performance information for the service (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent. •If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this potential requirement are also requested. •If a large business, provide if subcontracting opportunities exist for small business concerns. The government is not responsible for locating or securing any information, not identified in the response. Interested Contractors must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before December 3, 2013 by 9:00 hours (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, Field Operations Branch, FDA|OO|OFBA|OAGS|DAP, Attn: Sondea Blair, 3900 NCTR Road, HFT-320, Bldg 50, Rm 421 Jefferson, AR 72079-9502 or email sondea.blair@fda.hhs.gov. Reference FDA 1116032. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether or not any future requirement similar to this one should be set aside for small business, made available to full and open competition or procure through sole-source acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Offerors are afforded the opportunity to inspect the system by contacting the Contract Specialist identified herein to schedule an appointment. Failure to inspect the system will not relive the successful offeror from fully meeting the requirements of the resulting contract at the price offered. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). Additional Notes: If the stated requirements appear restrictive, please submit comments detailing the concern. Though this is not a request for quote, informational pricing for the service is encouraged.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA_1127464/listing.html)
- Place of Performance
- Address: US Food and Drug Administration, Center for Biologics Evaluation and Research, 8800 Rockville Pike, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN03239147-W 20131123/131121234413-e3219f77078549effe5710d10c526bee (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |